SynAct Pharma’s interim report for Q1 will be published on 19 April 2018

The Board of Directors of SynAct Pharma AB (publ) has announced that due to the previously announced and planned rights issue, the company has decided to advance the publication date of the interim report for the period January – March 2018 to April 19, instead of 9 May 2018 as previously communicated.

For further information about SynAct Pharma AB, please contact:

Jeppe Øvlesen                                                                                         Henrik Stage

CEO, SynAct Pharma AB                                                                   CFO, SynAct Pharma AB

Telephone: +45 28 44 75 67                                                            Telephone: +45 40 26 09 00
E-mail: joo@synactpharma.com                                                     E-mail: hs@synactpharma.com